Led by CEO Matthew Hammond and CBO/COO Henry Stusnick, the company intends to utilize the capital to pursue a merger or business combination. While the firm maintains the flexibility to target any sector, management plans to prioritize the healthcare industry, leveraging their specific sector expertise to identify and secure a target entity. The offering is expected to close on July 14, 2026.
Leerink Partners is acting as the sole bookrunning manager for the transaction. The financing attracted a broad range of institutional investors, including Adage Capital Partners, Perceptive Advisors, and Janus Henderson Investors. The company’s registration statement was declared effective by the SEC on July 10, 2026, and the offering is being conducted strictly through a prospectus.
Comments (0)
No comments yet. Be the first!